Back to JI Johnson Investment Counsel Inc.
ALXN
Showing 0 of 6 quarters
Position history for JIJohnson Investment Counsel Inc.'s holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Johnson Investment Counsel held 3,099 shares of ALXN (Alexion Pharmaceuticals), worth $569,000. Johnson Investment Counsel's 13F filings listed ALXN from Q2 2020 to Q2 2021, 5 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, State Street Corp.